Margaret V Ragni MD

PubMed

• The Iron Ladies: Prevalence and Risk Factors of Iron Deficiency in Females With Bleeding Disorders.
  Meghan McCormick, Jianzhong Hu, Martin Chandler, Matthew Manuel, Tammuella Chrisentery-Singleton
  Haemophilia. 2025-03-18
• Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B.
  Steven W Pipe, Toshko Lissitchkov, Pencho Georgiev, Sarah Mangles, Inga Hegemann
  Blood Advances. 2025-03-11
• Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.
  Francesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, Alessandro Casini, Giancarlo Castaman
  Hemasphere. 2025-03-01

Journal Articles

• BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A  
  Doris V Quon, Margaret V Ragni, The New England Journal of Medicine

Abstracts/Posters

• Mechanism of Pulmonary Thrombosis in Hemolytic Disorders
  Margaret V. Ragni, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Prolonged Circulation of Ultra-Large Von Willebrand Factor and a Reduction in ADAMTS13 Activity Promotes Microvascular Disease Following Traumatic Injury
  Margaret V. Ragni, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Innate Immune Mechanism of Hemarthrosis in Hemophilia-a Mice
  Margaret V. Ragni, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Emicizumab Prophylaxis in Patients with Hemophilia _ with and without Inhibitors
  Margaret V. Ragni, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute ...
  Margaret V. Ragni, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• FVIII Protein Is Not Detectable in Human PBMCs or Livers from Dogs with an Intron-22 Inversion Mutation: Implications for FVIII Immunogenicity and Tolerance
  Margaret V. Ragni, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Coagulation Conundrum Roundtable: Case-based Discussion on the Implications of Exogenous Estrogens in Hemostasis and Thrombosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Hemostasis and Thrombosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Scientific Communication: Explaining Your Science to a Lay Audience 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all